Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.40 |
| ▸ | CDC25B | P30305 | 7/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.39 |
| ▸ | FGF1 | P05230 | 2/20 | 0.38 |
| ▸ | FGF2 | P09038 | 2/20 | 0.38 |
| ▸ | VEGFA | P15692 | 2/20 | 0.38 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.37 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.37 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14075626 | 0.91 | LGALS8 (0.42) | NT5EPTPN1CDC25BFGF1FGF2 | |
| SCHEMBL472852 | 0.91 | LGALS8 (0.42) | NT5EPTPN1CDC25BFGF1FGF2 | |
| SCHEMBL2629582 | 0.91 | LGALS8 (0.42) | NT5EPTPN1CDC25BFGF1FGF2 | |
| SCHEMBL14409790 | 0.90 | NT5E (0.51) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL472876 | 0.90 | FGF1 (0.37) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL6552379 | 0.87 | PTPN1 (0.50) | NT5EPTPN1CDC25BPTPN2PTPN6 | |
| SCHEMBL13695054 | 0.85 | NT5E (0.36) | NT5EFGF1FGF2VEGFAHPSE | |
| SCHEMBL14075625 | 0.85 | NT5E (0.36) | NT5EFGF1FGF2VEGFAHPSE | |
| SCHEMBL2629592 | 0.83 | LGALS8 (0.48) | NT5EPTPN1CDC25BFGF1FGF2 | |
| SCHEMBL14409788 | 0.83 | LGALS8 (0.48) | NT5EPTPN1CDC25BFGF1FGF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412720-B1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | GLYTECH INC (JP) | 2015-10-21 | — | — | EP | disclosed |
| EP-1520858-B1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides | GLYTECH INC (JP) | 2013-11-27 | — | — | EP | disclosed |
| US-8399656-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2412720-A2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | Otsuka Chemical Co., Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-8063202-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | GLYTECH, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-1520858-A1 | PROCESS FOR PRODUCING SUGAR PEPTIDE HAVING ASPARAGINE SUGAR CHAIN AND THE SUGAR PEPTIDE | OTSUKA CHEMICAL COMPANY, LTD. (JP) | 2005-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | ASNS, BSG, ANPEP | NT5E 285/4885PTPN1 2272/4885CDC25B 4781/4885 |
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | ASNS, ANPEP, B3GNT2 | NT5E 325/4885PTPN1 2323/4885CDC25B 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.